Geode Capital Management
VTAE

Geode Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Geode Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-168,808
Closed -$3.53M – 4108
2016
Q3 		$3.53M Buy
168,808
+15,048
+10% +$173K ﹤0.01% 2183
2016
Q2 		$1.66M Buy
153,760
+69,750
+83% +$597K ﹤0.01% 2604
2016
Q1 		$556 Buy
84,010
+9,059
+12% +$82.4K ﹤0.01% 3169
2015
Q4 		$1.36M Buy
74,951
+114
+0.2% +$1.57K ﹤0.01% 2739
2015
Q3 		$823K Buy
74,837
+623
+0.8% +$6.62K ﹤0.01% 2976
2015
Q2 		$1.07M Buy
74,214
+6,773
+10% +$92K ﹤0.01% 2856
2015
Q1 		$789K Buy
67,441
+24,032
+55% +$324K ﹤0.01% 2992
2014
Q4 		$722K Buy
+43,409
New +$635K ﹤0.01% 3014

Geode Capital Management's VTAE Position: Q4 2016 in Review

Geode Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 168,808 shares — an estimated $3.53M sold.

Geode Capital Management first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $3.53M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Geode Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Geode Capital Management sold 168,808 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $3.53M.
  • Geode Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
  • Geode Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.53M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.